339
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies

ORCID Icon & ORCID Icon
Pages 1383-1399 | Received 19 Jun 2022, Accepted 11 Sep 2022, Published online: 28 Sep 2022

References

  • Barzaga Arencibia Z, Choonara I. Balancing the risks and benefits of the use of over-The-counter pain medications in children. Drug Saf. 2012;35(12):1119–1125. doi:10.1007/BF03261998
  • Zin CS. Prescribing of nonsteroidal anti-inflammatory drugs, tramadol, and opioids in children: patterns of its utilization. J Pharm Bioallied Sci. 2020;12(Suppl 2):S841–S845.
  • Dills R, Anderson LA, Pierce CA. The role of nonsteroidal anti‐inflammatory drugs in pediatric patients. Pharmacol Res. 2012;65(1):5‐8.
  • Neubert A, Verhamme K, Murray ML, et al. The prescribing of analgesics and non‐steroidal anti‐inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res. 2010;62(3):243‐248.
  • Gaffar J, Gabrielli S, Lavine E, et al. Diagnosis of Ibuprofen allergy through oral challenge. Clin Exp Allergy. 2020;50(5):636–639.
  • Lundgren M, Steed LJ, Tamura R, et al. Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity. BMC Pediatr. 2017;17(1):127.
  • Desborough MJR, Keeling DM. The aspirin story - from willow to wonder drug. Br J Haematol. 2017;177(5):674–683.
  • Maclagan T. The treatment of rheumatism by salicin and salicylic acid. Br Med J. 1876;1(803):627.
  • Cavkaytar O, du Toit G, Caimmi D. Characteristics of NSAID-induced hypersensitivity reactions in childhood. Pediatr Allergy Immunol. 2019;30(1):25–35.
  • Titchen T, Cranswick N, Beggs S. Adverse drug reactions to nonsteroidal anti‐inflammatory drugs, COX‐2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol. 2005;59(6):718‐723. doi:10.1111/j.1365-2125.2005.02444.x
  • Dona I, Blanca-Lopez N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol. 2012;22(5):363–371.
  • Rubio M, Bousquet PJ, Gomes E, Romano A, Demoly P. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy. 2012;42(1):123–130.
  • Jares EJ, Sanchez-Borges M, Cardona-Villa R, et al. Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol. 2014;113(3):282–289.
  • Silva Espinosa DL, Rojas Mejia DV, Ramirez Zuluaga LF, Olaya Hernandez M, Serrano Reyes CD. Descriptive analysis of a simplified approach to low-risk drug hypersensitivity reactions. Ann Allergy Asthma Immunol. 2021;126(2):162–167.
  • Jares EJ, Baena-Cagnani CE, Sanchez-Borges M, et al. Drug-induced anaphylaxis in Latin American Countries. J Allergy Clin Immunol Pract. 2015;3(5):780–788.
  • Mota I, Gaspar A, Benito-Garcia F, Correia M, Chambel M, Morais-Almeida M. Drug-induced anaphylaxis: seven-year single-center survey. Eur Ann Allergy Clin Immunol. 2018;50(5):211–216.
  • Aun MV, Blanca M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414–420.
  • Faria E, Rodrigues-Cernadas J, Gaspar A, et al. Drug-induced anaphylaxis survey in Portuguese Allergy Departments. J Investig Allergol Clin Immunol. 2014;24(1):40–48.
  • Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA Position Paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469–480.
  • Zisa G, Riccobono F, Bommarito L, et al. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions. Allergy Asthma Proc. 2012;33(5):421–426.
  • Makowska JS, Burney P, Jarvis D, et al. Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA(2) LEN) survey. Allergy. 2016;71(11):1603–1611.
  • Asero R. Single NSAID hypersensitivity is associated with atopic status. Eur Ann Allergy Clin Immunol. 2015;47(2):48–53.
  • Quiralte J, Blanco C, Delgado J, et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol. 2007;17(3):182–188.
  • Viola M, Rumi G, Valluzzi RL, Gaeta F, Caruso C, Romano A. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy. 2011;41(1):96‐103.
  • Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol. 2008;18(5):561–565.
  • Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy. 1980;35(2):149–154.
  • Calvo Campoverde K, Giner-Munoz MT, Martinez Valdez L, et al. Reacciones de hipersensibilidad a antiinflamatorios no esteroideos y su tolerancia a fármacos alternativos [Hypersensitivity reactions to non-steroidal anti-inflammatory drugs and tolerance to alternative drugs]. An Pediatr. 2016;84(3):148–153. Spanish.
  • Kidon MI, Kang LW, Chin CW, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 2005;116(5):e675–e680.
  • Kidon MI, Liew WK, Chiang WC, et al. Hypersensitivity to paracetamol in Asian children with early onset of nonsteroidal anti-inflammatory drug allergy. Int Arch Allergy Immunol. 2007;144(1):51–56.
  • Zambonino MA, Torres MJ, Munoz C, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol. 2013;24(2):151–159.
  • Cavkaytar O, Arik Yilmaz E, Karaatmaca B, et al. Different phenotypes of non-steroidal anti-inflammatory drug hypersensitivity during childhood. Int Arch Allergy Immunol. 2015;167(3):211–221.
  • Guvenir H, Dibek Misirlioglu E, Vezir E, et al. Nonsteroidal anti-inflammatory drug hypersensitivity among children. Allergy Asthma Proc. 2015;36(5):386–393.
  • Yilmaz Topal O, Kulhas Celik I, Turgay Yagmur I, et al. Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity. Ann Allergy Asthma Immunol. 2020;125(2):202–207.
  • Yilmaz O, Ertoy Karagol IH, Bakirtas A, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68(12):1555–1561.
  • Alves C, Romeira AM, Abreu C, Carreiro-Martins P, Gomes E, Leiria-Pinto P. Non-steroidal anti-inflammatory drug hypersensitivity in children. Allergol Immunopathol. 2017;45(1):40–47.
  • Arikoglu T, Aslan G, Yildirim DD, Batmaz SB, Kuyucu S. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children. Allergol Int. 2017;66(3):418–424.
  • Cousin M, Chiriac A, Molinari N, Demoly P, Caimmi D. Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. Pediatr Allergy Immunol. 2016;27(7):743–748.
  • Blanca-Lopez N, Haroun-Diaz E, Ruano FJ, et al. Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders. J Allergy Clin Immunol Pract. 2018;6(4):1226–1235.
  • Ertoy Karagol HI, Yilmaz O, Bakirtas A, Topal E, Demirsoy MS, Turktas I. Angioedema without urticaria in childhood. Pediatr Allergy Immunol. 2013;24(7):685–690.
  • Cavkaytar O, Arik Yilmaz E, Buyuktiryaki B, Sekerel BE, Sackesen C, Soyer OU. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria. Allergy. 2015;70(2):153–160.
  • Eser Simsek I, Cogurlu MT, Aydogan M. Two approaches for diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity in children. Ann Allergy Asthma Immunol. 2019;123(4):389–393.
  • Sipahi Cimen S, Yucel E, Ozceker D, et al. Behind the scene: paracetamol hypersensitivity in children. Pediatr Allergy Immunol. 2021;32(1):177–185.
  • Ibero M, Eseverri JL, Barroso C, Botey J. Dyes, preservatives and salicylates in the induction of food intolerance and/or hypersensitivity in children. Allergol Immunopathol. 1982;10(4):263–268.
  • Boussetta K, Ponvert C, Karila C, Bourgeois ML, Blic J, Scheinmann P. Hypersensitivity reactions to paracetamol in children: a study of 25 cases. Allergy. 2005;60(9):1174–1185.
  • Botey J, Ibero M, Malet A, Marin A, Eseverri JL. Aspirin-induced recurrent urticaria and recurrent angioedema in non-atopic children. Ann Allergy. 1984;53(3):265–267.
  • Guvenir H, Dibek Misirlioglu E, Capanoglu M, et al. The frequency of nonsteroidal anti-inflammatory drug hypersensitivity in children with asthma. Int Arch Allergy Immunol. 2018;176(1):26–32.
  • Rachelefsky GS, Coulson A, Siegel SC, Stiehm ER. Aspirin intolerance in chronic childhood asthma: detected by oral challenge. Pediatrics. 1975;56(3):443–448.
  • Schuhl JF, Pereyra JG. Oral acetylsalicylic acid (aspirin) challenge in asthmatic children. Clin Allergy. 1979;9(1):83–88.
  • Vedanthan PK, Menon MM, Bell TD, Bergin D. Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma. J Allergy Clin Immunol. 1977;60(1):8–13.
  • Fischer TJ, Guilfoile TD, Kesarwala HH, et al. Adverse pulmonary responses to aspirin and Acetaminophen in chronic childhood asthma. Pediatrics. 1983;71(3):313–318.
  • Towns SJ, Mellis CM. Role of acetyl salicylic acid and sodium metabisulfite in chronic childhood asthma. Pediatrics. 1984;73(5):631–637.
  • Hussein A. The incidence of analgesics intolerance in asthmatic children detected by history and inhalation challenge with lysine acetylsalicylate. Klin Padiatr. 1989;201(1):1–5.
  • Short JA, Barr CA, Palmer CD, Goddard JM, Stack CG, Primhak RA. Use of diclofenac in children with asthma. Anaesthesia. 2000;55(4):334–337.
  • Capriles-Behrens E, Caplin J, Sanchez-Borges M. NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol. 2000;10(5):277–279.
  • Debley JS, Carter ER, Gibson RL, Rosenfeld M, Redding GJ. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J Pediatr. 2005;147(2):233–238.
  • Soferman R, Tsivion A, Farber M, Sivan Y. The effect of a single dose of Acetaminophen on airways response in children with asthma. Clin Pediatr. 2013;52(1):42–48.
  • Falliers CJ. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol. 1973;52(3):141–147.
  • de Martino M, Chiarugi A, Boner A, Montini G, De’ Angelis GL. Working towards an appropriate use of ibuprofen in children: an evidence-based appraisal. Drugs. 2017;77(12):1295–1311.
  • Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016;71(2):149‐161.
  • Azh N, Barzkar F, Motamed-Gorji N, et al. Nonsteroidal anti-inflammatory drugs in acute viral respiratory tract infections: an updated systematic review. Pharmacol Res Perspect. 2022;10(2):e00925.
  • Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA. 1995;273(12):929–933.
  • Mori F, Atanaskovic-Markovic M, Blanca-Lopez N, et al. A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group. J Allergy Clin Immunol Pract. 2020;8(3):1022–1031. e1021.
  • Topal E, Celiksoy MH, Catal F, Gamze sayan Y, Sancak R. The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children. Allergy Asthma Proc. 2016;37(1):57–63.
  • Chandrasekharan NV, Dai H, Roos KL, et al. COX‐3, a cyclooxygen‐ase‐1 variant inhibited by Acetaminophen and other analgesic/anti‐pyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002;99(21):13926‐13931.
  • Gabrielli S, Langlois A, Ben-Shoshan M. Prevalence of hypersensitivity reactions in children associated with acetaminophen: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2018;176(2):106–114.
  • Szczeklik A. Analgesics. Chem Immunol Allergy. 2010;95:170–179.
  • Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231(25):232–235.
  • Blanca-Lopez N, Cornejo-Garcia JA, Perez-Alzate D, et al. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in children and adolescents: selective reactions. J Investig Allergol Clin Immunol. 2015;25(6):385–395.
  • Blanca-Lopez N, Cornejo-Garcia JA, Plaza-Seron MC, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs in children and adolescents: cross-intolerance reactions. J Investig Allergol Clin Immunol. 2015;25(4):259–269.
  • Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219–1232.
  • Pichler WJ. Immune pathomechanism and classification of drug hypersensitivity. Allergy. 2019;74(8):1457–1471.
  • Hagau N, Longrois D, Petrisor C. Threshold for positivity and optimal dipyrone concentration in flow cytometry-assisted basophil activation test. Allergy Asthma Immunol Res. 2013;5(6):383–388.
  • Gomez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy. 2009;39(8):1217–1224.
  • Phills JA, Perelmutter L. IgE mediated and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol. 1974;29(6):474–490.
  • Daxun Z, Becker WM, Schulz KH, Schlaak M. Sensitivity to aspirin: a new serological diagnostic method. J Investig Allergol Clin Immunol. 1993;3(2):72–78.
  • Grant JA, Weiler JM. A report of a rare immediate reaction after ingestion of Acetaminophen. Ann Allergy Asthma Immunol. 2001;87(3):227–229.
  • Scala E, Giani M, Pirrotta L, et al. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. J Allergy Clin Immunol. 2001;107(3):557.
  • Blanca-Lopez N, Soriano V, Garcia-Martin E, Canto G, Blanca M. NSAID-induced reactions: classification, prevalence, impact, and management strategies. J Asthma Allergy. 2019;12:217–233.
  • Ariza A, Garcia-Martin E, Salas M, et al. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole. Sci Rep. 2016;6:23845.
  • Perez-Alzate D, Cornejo-Garcia JA, Perez-Sanchez N, et al. Immediate reactions to more than 1 NSAID must not be considered cross-hypersensitivity unless tolerance to ASA is verified. J Investig Allergol Clin Immunol. 2017;27(1):32–39.
  • Dona I, Perez-Sanchez N, Eguiluz-Gracia I, et al. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Allergy. 2020;75(3):561–575.
  • Perez-Sanchez N, Bogas G, Cornejo-Garcia JA, et al. Multiple nonsteroidal anti-inflammatory drug hypersensitivity without hypersensitivity to aspirin. J Allergy Clin Immunol Pract. 2016;4(3):524–525.
  • Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy. 2014;69(4):420–437.
  • Ferrandiz-Pulido C, Garcia-Patos V. A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Arch Dis Child. 2013;98(12):998–1003.
  • Singh GK, Mitra B, Aro S, et al. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs). Int J Dermatol. 2021;60(5):579–588.
  • Prasad R, Gupta P, Singh A, Goel N. Drug induced pulmonary parenchymal disease. Drug Discov Ther. 2014;8(6):232–237.
  • Liccioli G, Mori F, Parronchi P, et al. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: a 9-year experience in a tertiary care paediatric hospital setting. Clin Exp Allergy. 2020;50(1):61–73.
  • Dibek Misirlioglu E, Guvenir H, Bahceci S, et al. Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study. J Allergy Clin Immunol Pract. 2017;5(3):757‐763.
  • Levi N, Bastuji‐Garin S, Mockenhaupt M, et al. Medications as risk factors of Stevens‐Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009;123(2):e297‐e304.
  • Del Pozzo‐Magana BR, Lazo‐Langner A, Carleton B, Castro‐Pastrana LI, Rieder MJ. A systematic review of treatment of drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol. 2011;18:e121‐e133.
  • Dogra S, Suri D, Saini AG, Rawat A, Sodhi KS. Fatal bronchiolitis obliterans complicating Stevens-Johnson syndrome following treatment with nimesulide: a case report. Ann Trop Paediatr. 2011;31(3):259–261.
  • Wang F, Zhao YK, Li M, Zhu Z, Zhang X. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study. Cutan Ocul Toxicol. 2017;36(4):370–376.
  • Ben Fadhel N, Chaabane A, Ammar H, et al. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption. Contact Dermatitis. 2019;81(5):336–340.
  • Nabavi M, Rezaeifar A, Sadeghinia A, et al. A case of linear iga bullous dermatosis induced by aspirin therapy. Iran J Allergy Asthma Immunol. 2020;19(5):550–554.
  • Gniazdowska B, Rueff F, Przybilla B. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs. Contact Dermatitis. 1999;40(2):63–65.
  • Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28–39.
  • Blanca‐Lopez N, Somoza‐Alvarez ML, Bellon T, Amo G, Canto G, Blanca M. NSAIDs hypersensitivity: questions not resolved. Curr Opin Allergy Clin Immunol. 2018;18(4):291‐301.
  • Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113(4):771‐775.
  • Hsieh CW, Lee JW, Liao EC, Tsai JJ. A disease marker for aspirin‐induced chronic urticaria. Int J Mol Sci. 2014;15(7):12591‐12603.
  • Campo P, Ayuso P, Salas M, et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy. 2013;68(8):1001‐1007. doi:10.1111/all.12187
  • Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol. 2004;15(4):376–380. doi:10.1111/j.1399-3038.2004.00159.x
  • Katz Y, Goldberg N, Kivity S. Localized periorbital edema induced by aspirin. Allergy. 1993;48(5):366‐369. doi:10.1111/j.1398-9995.1993.tb02407.x
  • Dona I, Blanca-Lopez N, Torres MJ, et al. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy. 2014;69(4):438–444. doi:10.1111/all.12335
  • Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy. 2011;66(7):818–829. doi:10.1111/j.1398-9995.2011.02557.x
  • Chen BS, Virant FS, Parikh SR, Manning SC. Aspirin sensitivity syndrome (Samter’s Triad): an unrecognized disorder in children with nasal polyposis. Int J Pediatr Otorhinolaryngol. 2013;77(2):281–283. doi:10.1016/j.ijporl.2012.10.017
  • Olze H, Lau S, Forster U. Samter’s triad and eicosanoid imbalance in children with recurrent nasal polyps. Pediatr Allergy Immunol. 2012;23(5):500. doi:10.1111/j.1399-3038.2012.01288.x
  • Tuttle KL, Schneider TR, Henrickson SE, et al. Aspirin-exacerbated respiratory disease: not always “adult-onset”. J Allergy Clin Immunol Pract. 2016;4(4):756–758. doi:10.1016/j.jaip.2016.05.016
  • Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328(7437):434. doi:10.1136/bmj.328.7437.434
  • Estrada Rodriguez JL, Florido Lopez JF, Belchi Hernandez J, et al. Asthma in children and ASA intolerance. J Investig Allergol Clin Immunol. 1993;3(6):315‐320.
  • King G, Byrne A, Fleming P. A case of severe NSAID exacerbated respiratory disease (NERD) following a dental procedure in a child. Eur Arch Paediatr Dent. 2016;17(4):277‐281. doi:10.1007/s40368-016-0233-0
  • Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000;16(3):432–436. doi:10.1034/j.1399-3003.2000.016003432.x
  • Bensko JC, McGill A, Palumbo M, Cahill KN, Laidlaw TM. Pediatric-onset aspirin-exacerbated respiratory disease: clinical characteristics, prevalence, and response to dupilumab. J Allergy Clin Immunol Pract. 2022;10(9):2466–2468. doi:10.1016/j.jaip.2022.05.016
  • Ertoy Karagol HI, Yilmaz O, Topal E, Ceylan A, Bakirtas A. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents. Int Forum Allergy Rhinol. 2015;5(5):392–398. doi:10.1002/alr.21494
  • Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014;133(1):e101–e106. doi:10.1016/j.jaci.2013.07.004
  • Thong BY, Lucas M, Kang HR, et al. Drug hypersensitivity reactions in Asia: regional issues and challenges. Asia Pac Allergy. 2020;10(1):e8. doi:10.5415/apallergy.2020.10.e8
  • Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol. 1996;98(3):678‐685. doi:10.1016/S0091-6749(96)70102-1
  • Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001;87(3):177–180. doi:10.1016/S1081-1206(10)62221-1
  • Sanchez-Lopez J, Araujo G, Cardona V, et al. Food-dependent NSAID-induced hypersensitivity (FDNIH) reactions: unraveling the clinical features and risk factors. Allergy. 2021;76(5):1480–1492.
  • Miceli Sopo S, Gelsomino M, Del Vescovo E, Bersani G. Food Dependent Exercise-Induced Anaphylaxis in pediatric age. Can we trust the oral food challenge with exercise and acetylsalicylic acid? Acta Biomed. 2020;92(1):e2021068.
  • Motomura C, Matsuzaki H, Ono R, et al. Aspirin is an enhancing factor for food-dependent exercise-induced anaphylaxis in children. Clin Exp Allergy. 2017;47(11):1497–1500.
  • Asaumi T, Yanagida N, Sato S, Shukuya A, Nishino M, Ebisawa M. Provocation tests for the diagnosis of food-dependent exercise-induced anaphylaxis. Pediatr Allergy Immunol. 2016;27(1):44–49.
  • Aihara M, Miyazawa M, Osuna H, et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol. 2002;146(3):466–472.
  • Pastorello EA, Zara C, Riario‐Sforza GG, Pravettoni V, Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to Acetaminophen and nimesulide in patients allergic to nonsteroidal anti‐inflammatory drugs. Allergy. 1998;53(9):880‐884.
  • Lee YS, Sun WZ. Epidemiology of anaphylaxis: a retrospective cohort study in Taiwan. Asian J Anesthesiol. 2017;55(1):9–12.
  • Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret‐Vautrin DA. Severe drug‐induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy. 2013;68(7):929‐937.
  • Sole D, Ivancevich JC, Borges MS, et al. Anaphylaxis in Latin American children and adolescents: the Online Latin American Survey on Anaphylaxis (OLASA). Allergol Immunopathol. 2012;40(6):331‐335.
  • Grabenhenrich LB, Dolle S, Moneret‐Vautrin A, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137(4):1128‐1137.
  • Sachs B, Dubrall D, Fischer-Barth W, Schmid M, Stingl J. Drug-induced anaphylactic reactions in children: a retrospective analysis of 159 validated spontaneous reports. Pharmacoepidemiol Drug Saf. 2019;28(3):377–388.
  • Gaspar A, Santos N, Piedade S, et al. One-year survey of paediatric anaphylaxis in an allergy department. Eur Ann Allergy Clin Immunol. 2015;47(6):197–205.
  • Ensina LF, de Lacerda AE, de Andrade DM, Machado L, Camelo-Nunes I, Sole D. Drug-induced anaphylaxis in children: nonsteroidal anti-inflammatory drugs and drug provocation test. J Allergy Clin Immunol Pract. 2014;2(6):825.
  • Cavkaytar O, Karaatmaca B, Cetinkaya PG, et al. Characteristics of drug-induced anaphylaxis in children and adolescents. Allergy Asthma Proc. 2017;38(5):56–63.
  • Brockow K, Garvey LH, Aberer W, et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702‐712.
  • Kowalski ML, Makowska JS. Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res. 2015;7(4):312‐320.
  • Dona I, Perez-Sanchez N, Bogas G, Moreno E, Salas M, Torres MJ. Medical algorithm: diagnosis and treatment of nonsteroidal antiinflammatory drugs hypersensitivity. Allergy. 2020;75(4):1003–1005.
  • Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general consider‐ations. Allergy. 2003;58(9):854‐863.
  • Topal OY, Ilknur KC, Irem YT, et al. Negative predictive value of provocation tests for nonsteroidal anti-inflammatory drugs in children. Allergy Asthma Proc. 2020;41(4):285–289.
  • Nohra D, Molinari N, Demoly P, Chiriac AM. Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugs. Allergy. 2020;75(6):1423–1434.
  • Misirlioglu ED, Toyran M, Capanoglu M, Kaya A, Civelek E, Kocabas CN. Negative predictive value of drug provocation tests in children. Pediatr Allergy Immunol. 2014;25(7):685–690.
  • Defrance C, Bousquet PJ, Demoly P. Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs. Allergy. 2011;66(11):1410–1414.
  • Dahlen B, Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J. 1990;3(5):527–534.
  • Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol. 1998;101(5):581–586.
  • Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62(10):1111–1118.
  • Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96(13):7563–7568.
  • Sanchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol. 2001;87(3):201–204.
  • Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol. 2005;94(1):34–38.
  • Loh W, Lim HH, Rao R, Goh A, Ong LX, Chiang WC. Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity. Asia Pac Allergy. 2015;5(1):40–46.
  • Corzo JL, Zambonino MA, Munoz C, et al. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs. Br J Dermatol. 2014;170(3):725–729.
  • Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of cross-sensitivity with Acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995;96(4):480–485.
  • Home page on the internet, European Medicines Agency. Available from: https://www.ema.europa.eu/en/documents/referral/nimesulide-article-107-procedures-annex-iii_en.pdf. Accessed May 31, 2022.
  • U.S. food and drug administration-drug safety data [Home page on the internet]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018084s052,017628s068lbl.pdf. Accessed May 31, 2022.
  • Li X, Zhou M, Xia Q, Li J. Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial. Can J Anaesth. 2016;63(3):268–274.
  • Murto K, Lamontagne C, McFaul C, et al. Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study. Can J Anaesth. 2015;62(7):785–797.
  • Heath JL, Heath RD, Tamboli C, et al. Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Ann Allergy Asthma Immunol. 2017;118(4):518–520.
  • Swierczynska-Krepa M, Sanak M, Bochenek G, et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. J Allergy Clin Immunol. 2014;134(4):883–890.